prgn-2009
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jun 24, 2020 (NCT04432597)
Timeline
Indications
Studied for
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06223568 | Phase 2 | Jun 10, 2024 | National Cancer Institute (NCI) |
| NCT06157151 | Phase 2 | Dec 3, 2023 | Intrexon, National Cancer Institute (NCI) |
| NCT05996523 | Phase 2 | Nov 7, 2023 | National Cancer Institute (NCI) |
| NCT04432597 | Phase 1/Phase 2 (Phase 2) | Jun 24, 2020 | National Cancer Institute (NCI) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 4 | 3 | 1 | 2020 |
| Intrexon | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1